Charlottesville company develops a test that predicts the severity of COVID-19 reaction
While it was once thought that only factors like age and being immunocompromised increased the chances of suffering the severe impacts of the COVID-19 virus, the medical community now knows that some people are genetically more susceptible to having a harsher reaction to the virus. In order to better predict patient outcomes, a local Charlottesville biotech company recently created a blood test that can predict whether or not a patient will have a severe reaction to COVID-19.